These results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 assist the strategy of targeting ACKR3 as a unique solution to modulate the opioid system, which could open up new therapeutic avenues for opioid-linked